Romaniuk-Drapala A, Toton E, Taube M, Idzik M, Rubis B, Lisiak N
Cancers (Basel). 2024; 16(13).
PMID: 39001543
PMC: 11240630.
DOI: 10.3390/cancers16132481.
Abdolahi M, Talkhounche P, Nazari M, Hosseininia H, Khoshdel-Rad N, Sadrabadi A
Bioinform Biol Insights. 2024; 18:11779322241227722.
PMID: 38318286
PMC: 10840405.
DOI: 10.1177/11779322241227722.
Sivaccumar J, Iaccarino E, Oliver A, Cantile M, Olimpieri P, Leonardi A
Pharmaceuticals (Basel). 2023; 16(8).
PMID: 37631045
PMC: 10459755.
DOI: 10.3390/ph16081130.
Nie J, Tang T, Wang Z, Zhang D, Wei J, Sheng W
J Int Med Res. 2023; 51(8):3000605231189129.
PMID: 37548409
PMC: 10408350.
DOI: 10.1177/03000605231189129.
Timar J, Honn K, Hendrix M, Marko-Varga G, Jalkanen S
Cancer Metastasis Rev. 2023; 42(1):323-334.
PMID: 36754910
PMC: 10014767.
DOI: 10.1007/s10555-023-10087-1.
Integrative Analysis of Histopathological Images and Genomic Data in Colon Adenocarcinoma.
Li H, Chen L, Zeng H, Liao Q, Ji J, Ma X
Front Oncol. 2021; 11:636451.
PMID: 34646756
PMC: 8504715.
DOI: 10.3389/fonc.2021.636451.
Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma.
Zhang N, Shi J, Shi X, Chen W, Liu J
Onco Targets Ther. 2020; 13:12797-12809.
PMID: 33363385
PMC: 7751839.
DOI: 10.2147/OTT.S275688.
Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry.
Zhang X, Zhang J, Zhou H, Fan G, Li Q
J Cancer. 2019; 10(25):6327-6340.
PMID: 31772665
PMC: 6856738.
DOI: 10.7150/jca.34171.
Kallikrein 6 protease advances colon tumorigenesis induction of the high mobility group A2 protein.
Chen H, Sells E, Pandey R, Abril E, Hsu C, Krouse R
Oncotarget. 2019; 10(58):6062-6078.
PMID: 31692974
PMC: 6817440.
DOI: 10.18632/oncotarget.27153.
PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
Sprouse M, Welte T, Boral D, Liu H, Yin W, Vishnoi M
Int J Mol Sci. 2019; 20(8).
PMID: 31003475
PMC: 6514876.
DOI: 10.3390/ijms20081916.
Correction: Development and Cancer: At the Crossroads of Nodal and Notch Signaling.
Cancer Res. 2018; 69(21):8526-8527.
PMID: 29323867
PMC: 5749931.
DOI: 10.1158/0008-5472.CAN-09-3534.
Targeting the Stem Cell Properties of Adult Breast Cancer Cells: Using Combinatorial Strategies to Overcome Drug Resistance.
Margaryan N, Seftor E, Seftor R, Hendrix M
Curr Mol Biol Rep. 2017; 3(3):159-164.
PMID: 29152453
PMC: 5687579.
DOI: 10.1007/s40610-017-0067-5.
Vg1-Nodal heterodimers are the endogenous inducers of mesendoderm.
Montague T, Schier A
Elife. 2017; 6.
PMID: 29140251
PMC: 5745085.
DOI: 10.7554/eLife.28183.
Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing.
Nakagaki T, Tamura M, Kobashi K, Koyama R, Fukushima H, Ohashi T
Oncotarget. 2017; 8(35):59113-59122.
PMID: 28938622
PMC: 5601718.
DOI: 10.18632/oncotarget.19262.
The Hedgehog Signaling Networks in Lung Cancer: The Mechanisms and Roles in Tumor Progression and Implications for Cancer Therapy.
Abe Y, Tanaka N
Biomed Res Int. 2017; 2016:7969286.
PMID: 28105432
PMC: 5220431.
DOI: 10.1155/2016/7969286.
Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling.
Jue C, Lin C, Zhisheng Z, Yayun Q, Feng J, Min Z
Oncotarget. 2016; 8(2):2501-2513.
PMID: 27705934
PMC: 5356819.
DOI: 10.18632/oncotarget.12388.
Nodal expression in triple-negative breast cancer: Cellular effects of its inhibition following doxorubicin treatment.
Bodenstine T, Chandler G, Reed D, Margaryan N, Gilgur A, Atkinson J
Cell Cycle. 2016; 15(9):1295-302.
PMID: 27007464
PMC: 4889232.
DOI: 10.1080/15384101.2016.1160981.
Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
Sasaki Y, Tamura M, Koyama R, Nakagaki T, Adachi Y, Tokino T
World J Gastroenterol. 2016; 22(7):2284-93.
PMID: 26900290
PMC: 4735002.
DOI: 10.3748/wjg.v22.i7.2284.
Tumor cell vascular mimicry: Novel targeting opportunity in melanoma.
Hendrix M, Seftor E, Seftor R, Chao J, Chien D, Chu Y
Pharmacol Ther. 2016; 159:83-92.
PMID: 26808163
PMC: 4779708.
DOI: 10.1016/j.pharmthera.2016.01.006.
Effects of a novel Nodal-targeting monoclonal antibody in melanoma.
Strizzi L, Sandomenico A, Margaryan N, Foca A, Sanguigno L, Bodenstine T
Oncotarget. 2015; 6(33):34071-86.
PMID: 26460952
PMC: 4741437.
DOI: 10.18632/oncotarget.6049.